-
1 Comment
Genesis Healthcare, Inc is currently in a long term downtrend where the price is trading 54.5% below its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.
Genesis Healthcare, Inc's total revenue sank by 19.1% to $919M since the same quarter in the previous year.
Its net income has increased by 32.7% to $-8M since the same quarter in the previous year.
Finally, its free cash flow grew by 154.4% to $21M since the same quarter in the previous year.
Based on the above factors, Genesis Healthcare, Inc gets an overall score of 3/5.
| Exchange | NASDAQ |
|---|---|
| CurrencyCode | USD |
| ISIN | US6687711084 |
| Sector | Technology |
| Industry | Software - Infrastructure |
| Market Cap | 18B |
|---|---|
| PE Ratio | 28.25 |
| Target Price | 30.9563 |
| Dividend Yield | 1.7% |
| Beta | 0.99 |
Gen Digital Inc. engages in the provision of cyber safety solutions for consumers. The company offers security and performance, identity protection, and online privacy, as well as technology platform. It offers its products under Norton, Avast, Avira, AVG, and CCleaner brands. The company was formerly known as NortonLifeLock Inc. and changed its name to Gen Digital Inc. in November 2022. Gen Digital Inc. was founded in 1982 and is headquartered in Tempe, Arizona.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for GEN using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
